BreathEazy - Respiratory Health Support

BreathEazy is a product designed to aid in respiratory health and support proper breathing.

BreathEazy FAQ

What is breathezy 10 mg used for?

Breathezy 10 MG Tablet is used to prevent and control the symptoms of asthma (narrowing of the airways). It is also used to prevent breathing difficulty during exercise. It also provides relief from the symptoms of allergy such as watery eyes, sneezing, difficulty in breathing, chest tightness, etc.

What are the side effects of breathezy 10 mg?

It works by preventing the narrowing of the windpipe and provides relief from allergic symptoms. Breathezy 10 MG Tablet may cause side effects like nausea, vomiting, headache, stomach pain, fever and diarrhoea. These effects are mild and may subside by themselves. Consult your doctor if they bother for a long time.

Can breathezy L 5 mg 10 mg be taken without food?

Breathezy L 5 mg/10 mg Tablet may be taken with or without food, but it is better to take it at a fixed time. Breathezy L 5 mg/10 mg Tablet is a combination of two medicines: Levocetirizine and Montelukast, which relieves sneezing and runny nose due to allergies.

What is breathezy L 5mg 10mg?

Breathezy L 5 mg/10 mg Tablet is a combination of two medicines: Levocetirizine and Montelukast, which relieves sneezing and runny nose due to allergies. Levocetirizine is an antiallergic which blocks a chemical messenger (histamine) responsible for runny nose, watery eyes and sneezing. Montelukast is a leukotriene antagonist.

What is the aetiology of breathlessness?

Over 2/3 of breathlessness is caused by cardiorespiratory disease. (8, 11a, 11b) 50% of breathlessness in adults over 40 years old is caused by heart failure, COPD, obesity, anaemia, anxiety, or depression. (12,13) The aetiology of breathlessness is multifactorial in about 1/3 of patients. (14)

What causes breathlessness?

Anxiety, depression, low physical activity and deconditioning are commonly associated with breathlessness. If a diagnosis is clear, undertake confirmatory investigations as appropriate and management of the condition. Reassess the patient after appropriate timescale.

What is the integrated Breathe Easy Group?

The British Lung Foundation is extending its Integrated Breathe Easy Group model, increasing the numbers of people living with lung conditions and their carers, who will benefit from peer support, health information and regular social and exercise activities.

How common is breathlessness?

Breathlessness is reported by around 9-11% (5, 6) of the general population, varying with severity, socioeconomic status (6, 7) and increasing with age to 25% in people over seventy years old (8, 9)